Castle Biosciences Champions National Initiatives for Skin Cancer Awareness Month

Castle Biosciences, Inc., a pioneer in healthcare diagnostics, is taking a leading role in promoting skin cancer awareness this May. The company is engaging in various initiatives nationwide to commemorate Skin Cancer Awareness Month, collaborating with esteemed organizations like AIM at Melanoma, the Melanoma Research Foundation (MRF), The Skin Cancer Foundation, IMPACT Melanoma, and The Sun Bus. Through these partnerships, the aim is to enhance public knowledge and improve early detection of skin cancer.

Advocacy and Community Engagement

Throughout the month, Castle Biosciences will participate in community events that include advocacy walks, cooperative skin cancer screenings, and extensive educational programs. Derek Maetzold, the CEO of Castle Biosciences, emphasized the importance of making skin cancer education and early detection more accessible: "Expanding access to skin cancer education and early detection resources is critical to improving patient outcomes, and we're committed to meeting people where they are."

Key Initiatives

1. Advocacy Walks and Educational Events: The collaboration with AIM at Melanoma and MRF involves engaging the community through advocacy walks that celebrate survivors, caregivers, and advocates joining forces to elevate awareness and support melanoma research.

2. Educational Programming: In partnership with MRF, Castle Biosciences will host several educational programs, including:
- Symposiums: Scheduled at red-hot centers like Fred Hutch Cancer Center (May 9) and Yale Cancer Center (May 12), these symposiums will focus on the latest developments in melanoma diagnosis and treatment, benefitting both patients and caregivers.
- Ask-the-Expert Webinar: An informative webinar titled "Understanding Melanoma Risk: How Prognostic Testing Can Help Guide Your Care" will take place on May 26, featuring experts who will answer participants' queries. This program aims to delve into melanoma basics and the significant role of gene expression profile testing in patient care planning.

3. Gala Event: A multi-year sponsorship of The Skin Cancer Foundation’s Champions for Change Gala on May 13 in New York City represents Castle Biosciences’ commitment to funding skin cancer education and prevention.

4. Community Screenings: On May 14, Castle will actively participate in the Nevada Cancer Coalition's Biggest Little Skin Check event in Reno, which includes free skin cancer screenings and engaging educational activities enhanced by collaborative efforts from IMPACT Melanoma.

5. Sun Bus Tour: A notable event included in Castle's initiatives is supporting The Sun Bus for two days of free skin cancer screenings in San Diego and Los Angeles on May 15 and 16. This mobile clinic represents a crucial pathway to educate individuals directly about sun safety and skin health, as highlighted by Dr. Tamara Terzain from The Sun Bus.

The Importance of Advocacy and Early Detection

The initiatives organized during Skin Cancer Awareness Month underline the seriousness of skin cancer, which affects millions across the nation. By partnering with expert organizations and reaching out to communities, Castle Biosciences is making significant strides in increasing awareness and encouraging early detection—two of the most vital components to combat skin cancer more effectively.

Castle Biosciences is determined to transform the landscape of skin cancer early diagnosis through these comprehensive outreach initiatives. The organization proudly empowers patients and healthcare professionals alike by providing essential resources and knowledge that can lead to better health outcomes.

About Castle Biosciences

Castle Biosciences, headquartered in Friendswood, Texas, is a publicly traded diagnostic company (Nasdaq: CSTL) focused on developing tests that improve patient care across various health conditions. With a commitment to utilizing cutting-edge science, Castle's innovative tests aim to guide more informed care decisions, ultimately enhancing patient management and treatment plans.

For further information about their initiatives and to learn more about skin cancer, interested individuals can visit Castle Biosciences’ official website.